Spruce Biosciences, Inc. SEC filings SPRB
Spruce Biosciences, Inc. has 366 filings in SEC EDGAR's recent list, going back to Feb 28, 2020. Its latest annual report, Form ARS, was filed on Apr 9, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 12, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 14, 2026 | — |
| 10-Q | Quarterly report | Aug 12, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2026 | Aug 12, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 4, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 30, 2026 | — |
| 4 | Insider transaction | Jul 29, 2026 | Jul 27, 2026 |
| 3 | Initial insider ownership | Jul 29, 2026 | Jul 27, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 27, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Jul 27, 2026 | Jul 27, 2026 |
| 4 | Insider transaction | Jul 9, 2026 | Jun 30, 2026 |
| 4 | Insider transaction | May 26, 2026 | May 21, 2026 |
| 4 | Insider transaction | May 26, 2026 | May 21, 2026 |
| 4 | Insider transaction | May 26, 2026 | May 21, 2026 |
| 4 | Insider transaction | May 26, 2026 | May 21, 2026 |
| 4 | Insider transaction | May 26, 2026 | May 21, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 26, 2026 | May 21, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| S-8 | Employee stock plan registration | May 13, 2026 | — |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 13, 2026 | May 13, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 7, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 28, 2026 | — |
| 8-K |
Current report
Material agreement, Other events
|
Apr 22, 2026 | Apr 20, 2026 |
| 424B5 | Prospectus supplement | Apr 21, 2026 | — |
| 424B5 | Prospectus supplement | Apr 20, 2026 | — |
| ARS | Annual report to shareholders | Apr 9, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 9, 2026 | — |
| DEF 14A | Proxy statement | Apr 9, 2026 | Apr 9, 2026 |
| 8-K |
Current report
Agreement ended
|
Mar 20, 2026 | Mar 16, 2026 |
| 4 | Insider transaction | Mar 9, 2026 | Mar 9, 2026 |
| 3 | Initial insider ownership | Mar 9, 2026 | Mar 9, 2026 |
| 424B5 | Prospectus supplement | Mar 9, 2026 | — |
| S-8 | Employee stock plan registration | Mar 9, 2026 | — |
| 8-K |
Current report
Material agreement, Agreement ended, Results of operations, Officer or director change
|
Mar 9, 2026 | Mar 9, 2026 |
| 10-K | Annual report | Mar 9, 2026 | Dec 31, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 24, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Feb 18, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 10, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Feb 5, 2026 | Feb 5, 2026 |
| 4 | Insider transaction | Jan 21, 2026 | Dec 11, 2025 |
| 8-K |
Current report
Material agreement, Results of operations, New debt, Unregistered share sale, Regulation FD disclosure
|
Jan 8, 2026 | Jan 7, 2026 |
| 4 | Insider transaction | Jan 5, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Dec 17, 2025 | Dec 15, 2025 |
| 4 | Insider transaction | Dec 17, 2025 | Dec 11, 2025 |
| 4 | Insider transaction | Dec 15, 2025 | Dec 11, 2025 |
| 4 | Insider transaction | Dec 15, 2025 | Dec 11, 2025 |
| 4 | Insider transaction | Dec 15, 2025 | Dec 11, 2025 |
| 4 | Insider transaction | Dec 15, 2025 | Dec 11, 2025 |
| 4 | Insider transaction | Dec 15, 2025 | Dec 11, 2025 |
| 4 | Insider transaction | Dec 15, 2025 | Dec 11, 2025 |
| 4 | Insider transaction | Dec 15, 2025 | Dec 11, 2025 |
| 3 | Initial insider ownership | Dec 15, 2025 | Dec 11, 2025 |
| 8-K |
Current report
Officer or director change
|
Dec 15, 2025 | Dec 11, 2025 |
| 4 | Insider transaction | Dec 12, 2025 | Dec 10, 2025 |
| 4 | Insider transaction | Dec 12, 2025 | Dec 10, 2025 |
| 424B3 | Prospectus | Dec 12, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Dec 12, 2025 | Dec 11, 2025 |
| EFFECT | Filing | Nov 26, 2025 | — |
| EFFECT | Filing | Nov 26, 2025 | — |
| CORRESP | Letter to the SEC | Nov 24, 2025 | — |
| CORRESP | Letter to the SEC | Nov 24, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 24, 2025 | — |
| 10-Q | Quarterly report | Nov 10, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2025 | Nov 10, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 7, 2025 | — |
| S-3 | Shelf registration | Oct 29, 2025 | — |
| S-3 | Shelf registration | Oct 29, 2025 | — |
| 4 | Insider transaction | Oct 22, 2025 | Oct 20, 2025 |
| 4 | Insider transaction | Oct 22, 2025 | Oct 20, 2025 |
| 8-K |
Current report
Officer or director change
|
Oct 17, 2025 | Oct 15, 2025 |
| D | Filing | Oct 17, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 16, 2025 | — |
| 4 | Insider transaction | Oct 15, 2025 | Oct 6, 2025 |
| 3 | Initial insider ownership | Oct 15, 2025 | Oct 6, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 15, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Oct 9, 2025 | — |
| 4 | Insider transaction | Oct 8, 2025 | Oct 6, 2025 |
| 3 | Initial insider ownership | Oct 8, 2025 | Oct 6, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Oct 8, 2025 | Oct 7, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 8, 2025 | — |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2025 | Aug 14, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 13, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 13, 2025 | — |
| 4 | Insider transaction | Jul 24, 2025 | Jul 22, 2025 |
| 4 | Insider transaction | Jul 24, 2025 | Jul 22, 2025 |
| 4 | Insider transaction | Jul 24, 2025 | Jul 22, 2025 |
| 4 | Insider transaction | Jul 24, 2025 | Jul 22, 2025 |
| 4 | Insider transaction | Jul 24, 2025 | Jul 22, 2025 |
| 4 | Insider transaction | Jul 24, 2025 | Jul 23, 2025 |
| 4 | Insider transaction | Jul 24, 2025 | Jul 22, 2025 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results, Regulation FD disclosure
|
Jul 24, 2025 | Jul 22, 2025 |
| 8-K |
Current report
Listing notice, Other events
|
Jun 12, 2025 | Jun 9, 2025 |
| DEFA14A | Additional proxy material | Jun 12, 2025 | — |
| DEFA14A | Additional proxy material | Jun 6, 2025 | — |
| DEFA14A | Additional proxy material | Jun 6, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Other events
|
May 29, 2025 | May 28, 2025 |
| 10-Q | Quarterly report | May 6, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 6, 2025 | May 6, 2025 |
| ARS | Annual report to shareholders | Apr 28, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 28, 2025 | — |
| DEF 14A | Proxy statement | Apr 28, 2025 | Jun 9, 2025 |
| 8-K |
Current report
Exit or restructuring costs, Listing notice
|
Apr 25, 2025 | Apr 21, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 18, 2025 | Jun 9, 2025 |
| S-8 | Employee stock plan registration | Apr 15, 2025 | — |
| 10-K | Annual report | Apr 15, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Apr 15, 2025 | Apr 15, 2025 |
| 8-K |
Current report
Results of operations
|
Apr 1, 2025 | Mar 31, 2025 |
| NT 10-K | Filing | Mar 31, 2025 | Dec 31, 2024 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jan 10, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Dec 27, 2024 | Dec 20, 2024 |
| 4 | Insider transaction | Dec 20, 2024 | Dec 10, 2024 |
| 4 | Insider transaction | Dec 20, 2024 | Dec 10, 2024 |
| 4 | Insider transaction | Dec 20, 2024 | Dec 10, 2024 |
| 8-K |
Current report
Other events
|
Dec 10, 2024 | Dec 10, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 12, 2024 | — |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2024 | Nov 11, 2024 |
| 8-K |
Current report
Listing notice
|
Oct 28, 2024 | Oct 24, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Oct 23, 2024 | — |
| 10-Q | Quarterly report | Aug 12, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2024 | Aug 12, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Jun 18, 2024 | Jun 13, 2024 |
| 8-K |
Current report
Other events
|
Jun 3, 2024 | Jun 2, 2024 |
| 4 | Insider transaction | May 24, 2024 | May 22, 2024 |
| 4 | Insider transaction | May 24, 2024 | May 22, 2024 |
| 4 | Insider transaction | May 24, 2024 | May 22, 2024 |
| 4 | Insider transaction | May 24, 2024 | May 22, 2024 |
| 4 | Insider transaction | May 24, 2024 | May 22, 2024 |
| 4 | Insider transaction | May 24, 2024 | May 22, 2024 |
| 4 | Insider transaction | May 24, 2024 | May 22, 2024 |
| 8-K |
Current report
Shareholder vote results
|
May 24, 2024 | May 22, 2024 |
| 10-Q | Quarterly report | May 13, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 13, 2024 | May 13, 2024 |
| 8-K |
Current report
Listing notice
|
Apr 30, 2024 | Apr 26, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Apr 25, 2024 | — |
| ARS | Annual report to shareholders | Apr 5, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 5, 2024 | — |
| DEF 14A | Proxy statement | Apr 5, 2024 | May 22, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Mar 28, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Mar 28, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Mar 25, 2024 | — |
| 4 | Insider transaction | Mar 25, 2024 | Mar 21, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Mar 20, 2024 | — |
| 4 | Insider transaction | Mar 20, 2024 | Mar 18, 2024 |
| 144 | Notice of proposed sale | Mar 18, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Mar 18, 2024 | — |
| 4 | Insider transaction | Mar 18, 2024 | Mar 14, 2024 |
| 4 | Insider transaction | Mar 18, 2024 | Mar 14, 2024 |
| 4 | Insider transaction | Mar 18, 2024 | Mar 14, 2024 |
| 4 | Insider transaction | Mar 18, 2024 | Mar 14, 2024 |
| S-8 | Employee stock plan registration | Mar 18, 2024 | — |
| 10-K | Annual report | Mar 18, 2024 | Dec 31, 2023 |
| 144 | Notice of proposed sale | Mar 14, 2024 | — |
| 8-K |
Current report
Results of operations, Exit or restructuring costs, Other events
|
Mar 13, 2024 | Mar 10, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Mar 7, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 6, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Jan 30, 2024 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Jan 8, 2024 | Jan 4, 2024 |
| 4 | Insider transaction | Jan 3, 2024 | Dec 29, 2023 |
| 4 | Insider transaction | Jan 3, 2024 | Dec 29, 2023 |
| 4 | Insider transaction | Dec 18, 2023 | Dec 14, 2023 |
| 4 | Insider transaction | Dec 18, 2023 | Dec 14, 2023 |
| 4 | Insider transaction | Dec 18, 2023 | Dec 14, 2023 |
| 4 | Insider transaction | Nov 28, 2023 | Nov 26, 2023 |
| 4 | Insider transaction | Nov 13, 2023 | Nov 8, 2023 |
| 10-Q | Quarterly report | Nov 13, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2023 | Nov 13, 2023 |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations, Other events
|
Aug 14, 2023 | Aug 14, 2023 |
| 4 | Insider transaction | Jul 5, 2023 | Jun 30, 2023 |
| 4 | Insider transaction | Jul 5, 2023 | Jun 30, 2023 |
| 4 | Insider transaction | Jul 5, 2023 | Jun 30, 2023 |
| SC 13D/A | Amended ownership over 5% (active) | May 30, 2023 | — |
| 4 | Insider transaction | May 26, 2023 | May 25, 2023 |
| 4 | Insider transaction | May 26, 2023 | May 25, 2023 |
| 4 | Insider transaction | May 26, 2023 | May 25, 2023 |
| 4 | Insider transaction | May 26, 2023 | May 25, 2023 |
| 4 | Insider transaction | May 26, 2023 | May 25, 2023 |
| 4 | Insider transaction | May 26, 2023 | May 25, 2023 |
| 4 | Insider transaction | May 26, 2023 | May 25, 2023 |
| 4 | Insider transaction | May 26, 2023 | May 25, 2023 |
| 3 | Initial insider ownership | May 26, 2023 | May 25, 2023 |
| 8-K |
Current report
Shareholder vote results
|
May 26, 2023 | May 25, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SPRB (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- South San Francisco, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1683553
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.